Free Trial

Novogen (KZIA) Insider Trading & Ownership

Novogen logo
$10.15 -0.12 (-1.17%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$9.67 -0.48 (-4.73%)
As of 07/18/2025 06:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novogen (NASDAQ:KZIA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.00%
Number Of
Insiders Buying
(Last 3 Years)
3
Amount Of
Insider Buying
(Last 3 Years)
$75.50K
Number Of
Insiders Selling
(Last 3 Years)
0
Get KZIA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Novogen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KZIA Insider Buying and Selling by Quarter

Novogen Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/20/2023Steven CoffeyInsiderBuy27,000$0.60$16,200.00
3/13/2023Bryce CarmineInsiderBuy27,000$0.60$16,200.00
3/3/2023Bryce CarmineInsiderBuy36,363$0.55$19,999.65
9/7/2022James GarnerInsiderBuy20,000$1.16$23,100.00
(Data available from 1/1/2013 forward)

KZIA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Novogen includes Bryce Carmine, James Garner, and Steven Coffey. Learn more on insiders at KZIA.

1.00% of Novogen stock is owned by insiders. Learn more on KZIA's insider holdings.

Novogen Key Executives

  • Dr. John Edwin Friend II (Age 54)
    M.D., CEO, MD & Director
    Compensation: $749.16k
  • Ms. Gabrielle Heaton BBUS (ACC)
    CPA, Principal Accounting Officer, VP of Finance & Administration and Principal Financial Officer
  • Ms. Anna Sandham
    Company Secretary


This page (NASDAQ:KZIA) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners